drugset / Trial / NCT07253324
ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of ENX-104 in participants with major depressive disorder with anhedonia (aMDD).
Timeline
- Start
- 2025-02-17
- Primary completion
- 2025-11-26
- Completion
- 2025-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENX-104 | Unknown | — | Oral |